Neuren Pharmaceuticals Limited

When Zevra Therapeutics, then known as KemPharm, bought arimoclomol for peanuts with its acquisition of Orphazyme in 2022, it looked like a great bit of business and further confirmation has come wi

Who: Acadia and Saniona What: The US biotech has licensed the Danish firm’s SAN711, a first-in-class highly selective GABAA-α3 positive allosteric modulator. Acadia is planning to initiate a Phase

Shares in Newron Pharmaceuticals SPA have been battered after the Italian drugmaker revealed that its Rett syndrome drug sarizotan has failed a Phase III trial in patients with the severe neurodevel

Japan’s Shionogi & Co. Ltd. has strengthened its existing links with research partner Tetra Therapeutics by increasing its ownership of the US-based venture to up to 50% through a new merger agree